Moleculin Biotech faces critical funding test as Annamycin’s 43% leukemia remission rate advances toward pivotal readout
PulseAI wins FDA clearance for smartwatch ECG analysis after study shows 92% fewer inconclusive results
Read More Healthcare Industry News RebrAIn expands capabilities with second FDA 510(k) clearance for OptimMRI software RebrAIn, a France-based precision neurosurgery platform, has achieved a significant milestone with its second FDA 510(k) clearance for… byPallavi MadhirajuAugust 30, 2024